Vardhaman Laboratories (Delisted) share price history
BSE: 524796Pharmaceuticals & Biotechnology
Last traded ₹0.51 on 16 Aug 2019
Delisted on 13 Jul 2022.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Feb 2019
8 Feb · Board meeting
Meeting on 14 Feb 2019: quarterly results
Jan 2019
21 Jan · Shareholding for the Period Ended December 31, 2018
Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....21 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2018
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the years to Mar 2009 and Mar 2015.Quarterly results
Quarter to Dec 2018, against the quarter beforeFiled 21 Feb
- RevenueRevenue. Under it, revenue in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.00 CrQuarter to Sep 2018: ₹0.00 Cr
- Net profit
- −₹0.01 Cr
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018Filed 21 Aug | Sep 2018Filed 27 Nov | Dec 2018Filed 21 Feb |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net profit | −0.04 | −0.03 | 0.00 | 0.00 | −0.01 | 0.00 | −0.01 | −0.01 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −100.0% | −325.0% | −33.3% | 27.3% | −133.3% | – | – | – |
Business segments
In the quarter to Dec 2018 the company reports one business segment, Pharmaceuticals, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2018, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −4.3% | – | – | 0.0% |
| 3 years | −23.1% | – | – | 0.0% |
Vardhaman Laboratories share price by year
Each calendar year to 2019.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2019 | 0.51 | −22.7% | 0.66 | 0.49 |
| 2018 | 0.66 | +4.8% | 0.66 | 0.63 |
| 2017 | 0.63 | −12.5% | 0.69 | 0.55 |
| 2016 | 0.72 | −55.3% | 1.77 | 0.68 |
| 2015 | 1.61 | −40.6% | 2.58 | 1.26 |
Recent sessions
The last 10 trading days to 16 Aug 2019, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 16 Aug 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 2,000 |
| 6 Aug 2019 | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 | 100 |
| 24 Jul 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 300 |
| 11 Jul 2019 | 0.53 | 0.53 | 0.49 | 0.49 | 0.51 | 500 |
| 4 Jun 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 100 |
| 3 May 2019 | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 | 100 |
| 24 Apr 2019 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 300 |
| 18 Apr 2019 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 500 |
| 16 Apr 2019 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 100 |
| 15 Apr 2019 | 0.60 | 0.60 | 0.57 | 0.57 | 0.59 | 700 |
Company details
- Legal name
- Vardhaman Laboratories Ltd.
- BSE code
- 524796
- ISIN
- INE503F01014
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Apr 1995
- Face value
- ₹10
- CIN
- L85195PN1985PLC036017
- Corporate identity number, the registrar of companies' code for it